Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Osage University Partners (OUP) is a leading venture capital fund investing exclusively in startups commercializing university research. With over $800M under management and partnerships with more than 100 universities and research institutions globally, OUP backs deep technology and life science startups at all stages. The firm has invested in over 130 portfolio companies with 33 IPOs to date.
OUP shares profits with affiliated academic institutions to further promote the university entrepreneurial ecosystem. It provides capital as well as strategic support for commercialization of scientific innovations emerging from academia.
OUP itself does not conduct clinical trials or have a therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Osage University Partners.